Prof. Ulf Landegren


undefinedAcademician of the Royal Swedish Academy of Sciences, Sweden

undefinedDepartment of Immunology, Genetics and Pathology, Uppsala University, Sweden


    Ulf Landegren received his MD and PhD in Uppsala University, before spending five years at California Institute of Technology. As professor of molecular medicine in Uppsala University, his research focuses on developing molecular tools to meet medical needs, from analyses of genetic variation with techniques such as oligonucleotide ligation assays and padlock probes to protein assays using oligonucleotide-conjugated antibodies inproximity assays for measuring protein expression levels in liquid samples orimaging their distribution in situ.

    Professor Landegren is a member of EMBO, the Royal Swedish Academy of Sciences and the Royal Society of Sciencesat Uppsala. He is member of several academic or industrial boards and advisoryboards. He has authored 224 peer-reviewed publications, and he is inventor of 49 patents or applications. Work in his lab has so far given rise to 12 spin-out companies with a combined staff of more than 700 people, including two companies that are now publicly traded (Olink Proteomics and Q-linea). Technologies from his lab have been licensed to many leading international biotech and diagnostic companies.